Download Free Sample Report

Global Resistant Pseudomonas Aeruginosa Infections Drugs Market Research Report 2022

Global Resistant Pseudomonas Aeruginosa Infections Drugs Market Research Report 2022

  • Published on : 30 November 2022
  • Pages :93
  • Report Code:SMR-7499060

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Semi-Synthetic Penicillin
Cephalosporin
Lactam Drugs
Others
Segment by Application
Hospital
Clinic
Home Care
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
ContraFect Corp
Inhibrx LP
Achaogen Inc
LegoChem Biosciences Inc
Melinta Therapeutics Inc
Novartis AG
AmpliPhi Biosciences Corp
Biolytics Pharma
Shionogi & Co Ltd